Results 261 to 270 of about 218,870 (301)

Mitochondrial Determinants of Doxorubicin-Induced Cardiomyopathy

Circulation Research, 2020
Kendall B Wallace, Vilma A Sardão, Paulo J Oliveira   +2 more
exaly  

Sustained alternate-day fasting potentiates doxorubicin cardiotoxicity

Cell Metabolism, 2023
Ali Javaheri
exaly  

Doxorubicin see Daunorubicin/doxorubicin

Reactions Weekly, 1991
openaire   +2 more sources

Doxorubicin Cardiomyopathy

Hospital Practice, 1982
openaire   +2 more sources

Doxorubicin Blocks Cardiomyocyte Autophagic Flux by Inhibiting Lysosome Acidification

Circulation, 2016
Dan L Li, Zhao V Wang, Xiang Luo
exaly  

Reduced cardiotoxicity and comparable efficacy in a phase IIItrial of pegylated liposomal doxorubicin HCl(CAELYX™/Doxil®) versus conventional doxorubicin forfirst-line treatment of metastatic breast cancer

Annals of Oncology, 2004
M E R O'Brien, M Inbar, Armando Santoro   +2 more
exaly  

Doxorubicin see Mitomycin/doxorubicin

Reactions, 1987
openaire   +1 more source

Chitosan-based nanoparticles as drug delivery systems for doxorubicin: Optimization and modelling

Carbohydrate Polymers, 2016
Paula I P Soares, Jorge Carvalho Silva, I Ferreira   +2 more
exaly  

Doxorubicin

Reactions Weekly, 2022
openaire   +2 more sources

Folate-receptor-targeted delivery of doxorubicin nano-aggregates stabilized by doxorubicin–PEG–folate conjugate

Journal of Controlled Release, 2004
Hyuk Sang Yoo
exaly